HER2 positivity is based on the amplification of the HER2 gene (HER2/chromosome enumeration probe 17 (CEP17) ratio ≥ 2.0) that causes complete, intense circumferential membranous expression of HER2 receptor in > 10% of cancer cells [8]. Here, ERBB2 is linked to cancer.